98 related articles for article (PubMed ID: 1380431)
1. Tropisetron, a new 5-HT3-receptor antagonist, in the prevention of radiation-induced nausea, vomiting and diarrhoea.
Sorbe B; Berglind AM
Drugs; 1992; 43 Suppl 3():33-9. PubMed ID: 1380431
[TBL] [Abstract][Full Text] [Related]
2. Tropisetron, a new 5-HT3 receptor antagonist, in the prevention of irradiation-induced nausea, vomiting and diarrhoea.
Sorbe B; Berglind AM; De Bruijn K
Eur J Gynaecol Oncol; 1992; 13(5):382-9. PubMed ID: 1486916
[TBL] [Abstract][Full Text] [Related]
3. Tropisetron, a new 5-HT3 receptor antagonist, in the prevention of radiation-induced emesis.
Sorbe B; Berglind AM; de Bruijn K
Radiother Oncol; 1992 Feb; 23(2):131-2. PubMed ID: 1546189
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy.
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):619-25. PubMed ID: 10348292
[TBL] [Abstract][Full Text] [Related]
5. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.
Simpson K; Spencer CM; McClellan KJ
Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164
[TBL] [Abstract][Full Text] [Related]
6. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
Jeremić B
Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
[TBL] [Abstract][Full Text] [Related]
7. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic tropisetron versus rescue tropisetron in fractionated radiotherapy to moderate or high emetogenic areas: a prospective randomized open label study in cancer patients.
Mystakidou K; Katsouda E; Linou A; Parpa E; Kouloulias V; Nikolaou V; Vlahos L
Med Oncol; 2006; 23(2):251-62. PubMed ID: 16720926
[TBL] [Abstract][Full Text] [Related]
9. Compassionate use of a 5-HT3-receptor antagonist, tropisetron, in patients refractory to standard antiemetic treatment.
Bleiberg H; Van Belle S; Paridaens R; De Wasch G; Dirix LY; Tjean M
Drugs; 1992; 43 Suppl 3():27-32. PubMed ID: 1380430
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients.
Aass N; Håtun DE; Thoresen M; Fosså SD
Radiother Oncol; 1997 Nov; 45(2):125-8. PubMed ID: 9424001
[TBL] [Abstract][Full Text] [Related]
11. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
12. Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.
Nicolaides C; Giannakakis T; Skarlos D; Athanassiadis A; Fountzilas G; Damigos D; Pavlidis N
J Exp Clin Cancer Res; 1998 Mar; 17(1):71-5. PubMed ID: 9646236
[TBL] [Abstract][Full Text] [Related]
13. Prevention of chemotherapy-induced nausea and emesis in patients responding poorly to previous antiemetic therapy. Comparing tropisetron with optimised standard antiemetic therapy.
Bruntsch U; Drechsler S; Hiller E; Eiermann W; Tulusan AH; Bühner M; Hartenstein R; Koenig HJ; Gallmeier WM
Drugs; 1992; 43 Suppl 3():23-6. PubMed ID: 1380429
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of prophylactic antiemetic treatment in cancer patients receiving radiotherapy.
Mystakidou K; Kouloulias V; Nikolaou V; Tsilika E; Lymperopoulou G; Balafouta M; Kouvaris I; Kelekis A; Gouliamos A
J BUON; 2010; 15(1):29-35. PubMed ID: 20414924
[TBL] [Abstract][Full Text] [Related]
15. The effect of antiemetics and reduced radiation fields on acute gastrointestinal morbidity of adjuvant radiotherapy in stage I seminoma of the testis: a randomized pilot study.
Khoo VS; Rainford K; Horwich A; Dearnaley DP
Clin Oncol (R Coll Radiol); 1997; 9(4):252-7. PubMed ID: 9315401
[TBL] [Abstract][Full Text] [Related]
16. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
17. Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930.
Dogliotti L; Faggiuolo R; Berruti A; Antonacci RA; Ortega C; Lancranjan I
Tumori; 1990 Dec; 76(6):595-8. PubMed ID: 2284699
[TBL] [Abstract][Full Text] [Related]
18. Study of efficacy and tolerability of tropisetron in the prevention of cisplatin induced nausea and vomiting.
Chiersilpa A; Ngow J
J Med Assoc Thai; 1999 Sep; 82(9):915-21. PubMed ID: 10561949
[TBL] [Abstract][Full Text] [Related]
19. Antiemetic efficacy of tropisetron in patients failing previous antiemetic therapy.
Falkson CI; Falkson HC
Oncology; 1995; 52(5):427-31. PubMed ID: 7637962
[TBL] [Abstract][Full Text] [Related]
20. Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients.
Dogliotti L; Antonacci RA; Pazè E; Ortega C; Berruti A; Faggiuolo R
Drugs; 1992; 43 Suppl 3():6-10. PubMed ID: 1380432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
